Biopharma companies can help healthcare providers and specialist physicians stay abreast of scientific and medical information. Sej Brar describes what it takes to reshape and transform the strategic relevance of the medical affairs function. Related Industry Life Sciences & Pharma
Life Sciences & Pharma Special Report The Evolution of Biomarker Use in Clinical Trials for Cancer Treatments November 26, 2019 The Evolution of Biomarker Use in Clinical Trials for Cancer Treatments: Key Findings and Implications documents the industry’s increasing commitment to…
Life Sciences & Pharma Executive Insights A Lasting Legacy: Building a Successful Business From Established Brands November 21, 2019 Legacy brands can form the foundation of a successful business, particularly for specialized players with the appropriate organizational structure and the…
Biotech and Pharmaceuticals Published Articles 5 Essential Factors For A Successful Biopharma Product Launch October 23, 2019 Rapid changes in the biopharma industry are making it increasingly difficult to launch new products successfully.
Consumer Products Executive Insights The Nutrigenetics Opportunity: Poised for Growth June 5, 2019 As genetic testing has emerged as one of the fastest-growing areas of consumer healthcare, sales of direct-to-consumer (DTC) solutions from companies like…
Life Sciences & Pharma Special Report Weighing the Trade-offs of a Direct Presence in Japan’s Rare and Orphan Drug Market February 20, 2020 In recent years, there has been a marked uptick in the number of rare and orphan companies establishing local operations in Japan to steward their…
Life Sciences & Pharma Video A Tale of Two Markets: Precision Medicine in China and Japan March 2, 2020 L.E.K.’s Alex Vadas gives his take on precision medicine in China and Japan.
